Class Action Filed Against Avandia
A class action lawsuit has been filed against GlaxoSmithKline, saying that the drug company did not do enough to alert those taking the drug of the drug's risk. The lawsuit was filed at the Court of Queen's Bench in Regina on the behalf of a 75-year-old woman who died in May after having taken Avandia.
Avandia was approved for the treatment of Type 2 diabetes in March 2000. Tony Merchant, the lawyer representing the plaintiff's estate, says of the lawsuit: "People have to have informed consent. They have to know what the risks are ... And that affords people the opportunity to really decide. That's where we think Avandia fell down." A spokesperson for GlaxoSmithKline in Toronto says that the company has not yet heard of any Canadian class action lawsuit.
Related Links:
Legal View: Avandia
Avandia Clears a Hurdle
A Challenging Prescription
Is Avandia Safe? Depends On Who You Talk To
Avandia Handicapped: Outlook Isn't Good, Could Be Worse